Attached a photo of this terribly disabling condition that affects the lives of so many people around the world.
with no current drug to address the growth of these cysts, patients have few or no alternatives other than dialysis.
i understand PYC have tested their drug candidate already on human tissue donated from amputated kidneys and also from diseased human tissue derived from stem cell research in a Perth laboratory.
The drug presumably works under microscope and the next step must be human trials in 2025.
An assessment of toxicity risk in humans is likely to have already been addressed by some primate testing, and perhaps other posters may be better informed and willing to share any details on that.
A speculative perspective for all to consider here is that this one drug alone could generate profits far beyond the realms of any other drug company in Australia, including CSL.
PYC Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)